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In contrast to immunity against some other facultative intracellular parasites, protective immunity against
Brucella abortus is mediated in mice by antibodies as well as by cell-mediated immune responses. It was the
purpose of this study to determine whether antibody alone would prevent infection with B. abortus. The
majority (82%) of CD-1 outbred mice infected with 100 CFU of virulent B. abortus 2308 preincubated with
graded quantities of an 0 polysaccharide-specific IgG2a monoclonal antibody (MAb) were free of infection 1,
2, 4, and 6 weeks later, based on detection limits of 13 brucellae per spleen and 39 per liver. Infection was
present in 95% of control animals. Similar results were obtained with a challenge dose of 500 CFU, but with
a challenge dose of 5,000 CFU, infection became established even with the highest concentration of MAb used
(50 ,ug of MAb per 5,000 brucellae). Pretreatment with an 0 polysaccharide-specific IgGl MAb or with
convalescent-phase serum diminished but did not prevent establishment of infection by 100 CFU of B. abortus.
A majority of culture-negative mice tested 6 weeks after infection were serologically negative, which could have
signified either the absence of previous infection or the early elimination of infection. In an in vitro test system,
all of the antibody preparations were efficient in opsonizing B. abortus. Effective killing of the organism by
unelicited mouse peritoneal macrophages occurred in conventional but not in endotoxin-free medium,
suggesting that activated macrophages were required for killing of opsonized B. abortus. These results
emphasize the potential importance of antibodies in the immunoprophylaxis of brucellosis and suggest that the
design of a successful vaccine will require the induction of antibodies not only of appropriate specificity but also
of the optimal isotype for mediating protective functions.
Although it has been demonstrated repeatedly in the
murine model that passively administered antibody en-
hances protective immunity against the facultative intracel-
lular bacterium Brucella abortus (1, 13-16, 19, 22, 26),
antibody titers induced by vaccines in cattle continue to be
regarded as undesirable because they interfere with the
interpretation of serodiagnostic tests. However, if it were
possible to demonstrate that antibodies alone could not only
diminish but also prevent the establishment of B. abortus
infection in mice, there would be cause to examine more
critically the role of humoral immunity in bovine brucellosis
and perhaps to reevaluate some of the criteria placed on the
composition of an ideal vaccine.
This study examined further the role of passive antibody
in murine brucellosis. It was our intention to determine
whether, under appropriate experimental conditions, anti-
body was capable of preventing infection with B. abortus.
Monoclonal antibodies specific for the 0 polysaccharide
were selected because such antibodies had been shown to
enhance protection (13, 16). In vitro phagocytosis and killing
assays were performed with the same antibodies for com-
parison with the in vivo experiments. Functional compari-
sons were also made between the monoclonal antibodies and
immune serum from convalescent mice.
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MATERIALS AND METHODS
Mice. BALB/c ByJ mice were obtained from the Jackson
Laboratory, Bar Harbor, Maine, and outbred CD-1 mice
were obtained from Charles River Breeding Laboratories,
Inc., Kingston, N.Y. Females were purchased at 9 weeks of
age and kept for 1 week before use.
Bacterial strains. Virulent B. abortus 2308 was used in all
experiments. For mouse challenge infections, frozen stock
cultures of predetermined concentration were diluted di-
rectly to the desired level in phosphate-buffered saline (PBS)
and injected intravenously. For in vitro challenge of murine
macrophages, 2-day plate cultures were suspended in PBS
and were adjusted turbidimetrically to the desired concen-
tration (15). Exact doses for in vivo and in vitro experiments
were established retrospectively by plate counts (15).
Antibodies for passive transfer. Two murine monoclonal
antibodies (MAb) with specificity for the B. abortus 0
polysaccharide were used. An immunoglobulin G2a (IgG2a)
MAb produced by clone 34 (16) was grown in tissue culture
and had been freed of antibiotics by affinity chromatography
and filter sterilized. It was held at 4°C at a final concentration
of 2.67 mg/ml. Antibodies produced by clone 34 had been
demonstrated previously to confer protection upon mice
(16). The antibodies were of high affinity (Ka = 7.6 x
1010/mol) and reacted strongly in agglutination and comple-
ment fixation tests and the enzyme-linked immunosorbent
assay (16).
An IgGl MAb specific for the A epitope of the B. abortus
O polysaccharide (6) was received as 1 ml of lyophilized
ascitic fluid. The preparation was reconstituted to 10 ml with
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PBS, dialyzed in PBS for 24 h to remove NaN3, filter
sterilized, and frozen in 1-ml aliquots at -70°C.
Polyclonal antiserum consisted of pooled sera from two
mice which had been infected 9 weeks previously with 5 x
104 live cells of B. abortus vaccine strain 19. The serum was
filter sterilized and frozen at -20°C prior to use. Samples
used for in vitro assays were heat inactivated at 56°C for 30
min.
Mouse studies. Mice were given 100 ,ul of a bacterial
suspension by injection into the tail vein. In protection
experiments the bacterial suspension had been premixed
with antibody or PBS on a rotator for 30 min at 37°C. Mice
were anesthetized with Metofane (Pitman-Moore, Inc.,
Washington Crossing, N.J.) before being exsanguinated by
cardiac puncture and cervical dislocation. The spleen and, in
most experiments, the left lateral lobe of the liver were
removed, homogenized, and cultured quantitatively by
methods previously described (15). Individual serum sam-
ples were frozen at -20°C until tested for antibodies.
Macrophage studies. Methods for assessment of opsoniza-
tion and killing in vitro followed in essentials the protocol of
Spitalny and North (24). Cells were removed from the
peritoneal cavities of normal CD-1 mice by washing, pooled,
and allowed to settle for 2 h onto circular cover slips
(diameter, 13 mm; Clay Adams, Parsippany, N.J.) in petri
dishes (35 by 10 mm; Becton Dickinson Labware, Oxnard,
Calif.) overlaid with 1 ml of medium. Nonadherent cells
were removed after a 2-h incubation at 37°C under 5% C02,
and adherent cells (approximately 1 x 105 per cover slip)
were incubated for another 1 h prior to the addition of
bacteria. A 1-ml volume of a fresh suspension of B. abortus
2308 which had been opsonized for 30 min at 37°C was added
to each plate. In most experiments the final concentration of
B. abortus was approximately 108 per ml, and a period of 15
min was allowed for phagocytosis. Individual cover slips
were then washed thoroughly, placed into new plates with
fresh medium, and reincubated. At this time (time zero) and
at periodic intervals thereafter, triplicate sets of cover slips
were washed, subjected to three cycles of freezing in a
dry-ice-alcohol bath and thawing in a 37°C water bath (12),
and cultured quantitatively. It had been established that this
treatment caused complete lysis of eucaryotic cells without
affecting the viability of B. abortus. Medium was changed in
each plate at 2-h intervals throughout the experiment. Cul-
tures were maintained in antibiotic-free RPMI 1640 (GIBCO
Laboratories, Grand Island, N.Y.) containing 5% heat-
inactivated (56°C for 1 h) fetal bovine serum (Sigma Chem-
ical Co., St. Louis, Mo.) and 5 U of preservative-free
heparin per ml. Washes were performed with sterile saline
containing 0.5% heat-inactivated fetal bovine serum. Con-
centrations of endotoxin in the RPMI 1640 and the fetal
bovine serum were 2.0 and <6.0 endotoxin units (EU/ml,
respectively, as determined by the Limulus lysate assay
(LAL 20 Test Kit; Whittaker Bioproducts, Walkersville,
Md.). Selected experiments were performed with endotoxin-
free RPMI 1640 (<0.01 EU/ml; Whittaker) containing the
same fetal bovine serum at a concentration of 5%. In
experiments in which endotoxin-free RPMI 1640 was used,
the saline solution used for washing was prepared with
endotoxin-free deionized distilled water (<0.02 EU/per ml;
Whittaker) and glassware was freed of pyrogens by baking at
170°C for 4 h.
Enzyme immunoassay. Antigen-coated microdilution wells
(Nunc, high antigen binding; InterLab, Thousand Oaks,
Calif.) were prepared by the addition to each well of 100 ,ul
of f6, a purified preparation of smooth lipopolysaccharide
(LPS) from B. abortus (20, 30), at 2.5 ,ug/ml in carbonate
buffer (pH 9.6). Coated plates were frozen and then thawed
1 to 2 h before use. Washing consisted of four 200-1ul rinses
with PBS containing 0.05% Tween 20. External dilutions of
serum were made in a solution of Tris-buffered saline (0.02
M Tris [pH 8.0]) containing 0.05% Tween 20 and 0.01%
NaN3. A 100-,lI quantity of each test serum was added in
duplicate, and the mixtures were incubated overnight at 4°C.
After washing, 100 pA of alkaline phosphate-conjugated goat
anti-mouse F(ab')2 (Jackson ImmunoResearch Laboratories,
Inc., West Grove, Pa.) was added for a 3-h incubation at
room temperature. After washing, 100 pA of the substrate
p-nitrophenyl phosphate (Sigma) was added at 1 mg/ml in
diethanolamine buffer (pH 9.8); then the mixture was alter-
nately shaken and read at 405 nm three times at 2-min
intervals on a plate reader (model 311; Biotek). Slope values
were obtained for each test sample by using the linear
regression function of Lotus 1-2-3. A linear relationship has
been demonstrated between antibody titers and the log of the
slope value (30). Three prediluted standards were included
on each plate and used to normalize readings for compari-
sons among plates.
Statistical methods. A mean value for each bacterial count
was obtained by averaging the triplicate values following log
conversion (15). Liver counts were adjusted to account for
culturing only the left lateral lobe, which made up one-third
of the organ. Where required, sufficient quantities of tissue
homogenates were plated to permit limits of detection esti-
mated at 13 colonies per spleen and 39 colonies per liver.
Thus, spleens and livers in which no colonies were detected
in any of the triplicates were assigned numbers of 12 and 38,
respectively. Statistical significance was determined by a
one-way analysis of variance. Individual comparisons were
made with paired one-way t tests (23).
RESULTS
Passive protection experiments. Preliminary experiments in
which B. abortus was opsonized with the IgGl MAb dem-
onstrated that infection could be reduced but not prevented
with the challenge dose (5 x 104 organisms) conventionally
used in this laboratory (15, 16, 29, 30). Lower challenge
doses were therefore evaluated in BALB/c and CD-1 mice to
determine the lowest dose which would establish a chronic
infection. The level of the plateau phase decreased with
lower challenge doses, and B. abortus grew to somewhat
smaller numbers in spleens of CD-1 mice. Based on these
results, most subsequent experiments were performed with
an infection dose of 100 CFU in CD-1 mice. It must be
emphasized that over the course of a year, a number of
experiments that were initiated with this low infection dose
showed unacceptably low levels of infection in a majority of
control mice of a given shipment. This occurred with both
strains of mice, despite procurement of mice from the same
vendors, the use of the same stocks of bacteria for infection,
and every effort to keep environmental conditions constant.
Lot-to-lot variations in mice, resulting in variable responses
to vaccination and challenge infections, have been noted
previously (30).
An initial trial with an infection dose of 100 CFU op-
sonized with three concentrations of the IgG2a MAb (50, 10,
and 1 ,ug/100 pLA containing 100 CFU) demonstrated excellent
protection at 1 and 2 weeks postinoculation (p.i.) (data not
shown). This experiment was repeated and extended to a
period of 6 weeks. Although 19 of 20 control mice (95%)
were infected at the four time points tested (1, 2, 4, and 6
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FIG. 1. Growth of B. abortus 2308 in livers and spleens of CD-1
mice infected with approximately 100 CFU of unopsonized organ-
isms or organisms opsonized with graded quantities of an IgG2a
MAb. There were five mice per treatment group; bars indicate
standard deviations. Dotted lines at log1o 1.59 and log1o 1.12
represent the limit of detection of organisms in the liver and spleen,
respectively.
weeks), only 11 of 60 antibody-treated mice (18%) had
detectable infections in the liver or spleen (Fig. 1). A mouse
was considered infected if a single colony was isolated from
either of the organs cultured (Fig. la). There was no appar-
ent difference among treatment groups in the total number of
mice infected over the course of the experiment. Moreover,
the numbers of organisms isolated from the antibody-
treated, infected mice were extremely small (Fig. lb and c),
and those isolated from the spleen were significantly smaller
than those of the control groups at each time point (P < 0.05
to P < 0.001). In the liver differences were significant at 1
week p.i. (50-,ug group) and 4 weeks p.i. (all groups) (P <
0.05).
The effectiveness of the IgG2a MAb against higher infec-
tion doses (500 and 5,000 CFU) was evaluated at 1, 2, and 4
weeks p.i. by using the highest concentration of antibody (50
,ug/100 ,ul containing 500 or 5,000 organisms, respectively)
used in the previous experiment. At the lower infection
dose, only 4 of the 15 antibody-treated mice (27%) were
infected (Fig. 2a). Detectable infections were restricted to
the spleen (Fig. 2b and c), in which the numbers of organ-
isms cultured were extremely small and differed significantly
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FIG. 2. Growth of B. abortus 2308 in livers and spleens of CD-1
mice infected with approximately 500 (a, b, and c) or 5,000 (d, e, and
f) CFU in 100 Ili, unopsonized or opsonized with 50 ,ug of an IgG2a
MAb. There were five mice per treatment group; bars indicate
standard deviations. Dotted lines at log1o 1.59 and log1o 1.12
represent the limit of detection of organisms in the liver and spleen,
respectively.
from those in the control groups (spleen, P < 0.01 to P <
0.001). At a challenge dose of 5,000 CFU all mice were
infected (Fig. 2d), although in antibody-treated mice the
numbers of brucellae recovered from the livers and spleens
were significantly smaller (spleen, P < 0.001; liver P < 0.05
to P < 0.01) at each time point, and infections were nearly
undetectable by 4 weeks p.i. (Fig. 2e and f).
The IgGl MAb was evaluated in CD-1 mice by using three
10-fold dilutions of antibody (containing 10, 1, and 0.1 pl of
reconstituted MAb per 100 .ld) and an infecting dose of 100
CFU. There was a significant reduction in spleen counts of
antibody-treated mice in all three treatment groups at 1 week
p.i. and in two of the three groups at 2 weeks p.i. (P < 0.01
to P < 0.001) (Table 1). However, the number of infected
mice increased in each group from week 1 to week 2 p.i., and
14 of the 15 antibody-treated mice (93%) were infected by
week 2 (Table 1).
An experiment of the same design was conducted with
convalescent-phase serum from mice which had been in-
fected with strain 19. CD-1 mice were injected with 100
brucellae which had been opsonized with antiserum in
dilutions of 1:5, 1:50, or 1:500. At weeks 1 and 2 p.i., 29 of
30 mice (97%) given opsonized bacteria were infected,
whereas at 4 and 6 weeks p.i., the number of infected mice
in the treated groups had decreased to 5 of 30 (17%) and
clearance was complete in the groups which had received
cells opsonized with the intermediate dilution of antiserum
(Fig. 3a). Bacterial counts in the spleens of antibody-treated
mice were significantly lower (P < 0.05 to P < 0.001) in all
groups at all time points, with the exception of the group
given the 1:500 dilution at 6 weeks p.i. (Fig. 3c). In accord
with prior observations (21), liver counts of antibody-treated
mice in two of three groups (1:5 and 1:500) were significantly
higher than those of control groups at 1 week p.i. (P < 0.05),
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TABLE 1. Effect of opsonization of B. abortus with an IgGl
MAb on the establishment of infection in micea
Week Amt of MAb Log1o brucellae No. infectedprmouseb in spleensp.i. (ILI) (mean ± SD)C per group
1 10.0 1.33 ± 0.51*** 1
1.0 1.54 ± 0.60** 3
0.1 1.74 ± 0.60** 3
0 3.13 ± 0.28 5
2 10.0 1.46 ± 0.34*** 4
1.0 1.85 ± 0.54** 5
0.1 2.99 ± 0.23 (NS) 5
0 3.40 ± 0.48 5
aInfection was performed intravenously with approximately 100 CFU of
B. abortus 2308 following incubation for 30 min at 37°C with graded concen-
trations of MAb.
b Quantities represent 1:10 dilutions of ascitic fluid in PBS. Thus, 10 RI
would contain 1.0 RI of undiluted ascitic fluid.
I In comparisons with untreated control groups: ***, P < 0.001; **, P <
0.01; NS, not significant.
d There were five mice per group.
but counts of all treated groups were significantly lower (P <
0.05) at 4 weeks p.i. (Fig. 3b).
Antibody responses following infection. Antibody re-
sponses and spleen counts of individual mice infected 6
weeks previously with B. abortus pretreated with the IgG2a
MAb or with polyclonal antiserum are presented in Tables 2
and 3, respectively. Of 15 mice in each group infected with
opsonized bacteria, 9 displayed antibody responses compa-
rable to those in normal mice (slopes, <16). All of these were
culture negative (Tables 2 and 3). The remaining 12 animals
had moderate to high antibody responses in conjunction with
culture-negative (10 mice) or culture-positive status (Tables
2 and 3). The antibody levels of the five mice treated with the
1:5 serum dilution were quite uniform and may have repre-
sented residual levels of transferred antibodies (Table 3). Of
12 control mice, 11 were culture positive and all had mod-
erate to high antibody responses. However, there was no
consistent relationship between the numbers of brucellae in
the spleen and the level of the antibody response (Tables 2
and 3).
Opsonization and killing assays in vitro. Results of repre-
sentative experiments are shown in Fig. 4. Ingestion of B.
abortus 2308 was negligible in the absence of antibodies but
was effectively facilitated by both of the MAbs and by the
polyclonal antiserum used in the passive-transfer experi-
ments (Fig. 4). The total number of brucellae ingested was
related directly to the concentrations of bacteria and anti-
bodies used and to the time permitted for phagocytosis (data
not shown). A time of 15 min was selected for phagocytosis
to prevent an underestimation of intracellular killing, be-
cause in conventional medium up to 30% of the ingested
brucellae were killed within the first hour (data not shown).
When concentrations of opsonizing antibodies were adjusted
to permit an approximately equivalent uptake of B. abortus,
bacterial killing in conventional medium was efficient and
followed similar kinetics with all three preparations. By 4 h
after phagocytosis, 90% or more of the ingested organisms
had been killed (Fig. 4a). In endotoxin-free medium, on the
other hand, phagocytosis was uniformly diminished and the
rates of killing were dramatically reduced, in particular
following opsonization with whole serum when initial repli-
cation occurred (Fig. 4b).
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FIG. 3. Growth of B. abortus 2308 in livers and spleens of CD-1
mice infected with approximately 100 CFU of unopsonized organ-
isms or organisms opsonized with graded quantities of a polyclonal
antiserum. There were five mice per treatment group; bars indicate
standard deviations. Dotted lines at log10 1.59 and log1o 1.12
represent the limit of detection of organisms in the liver and spleen,
respectively.
DISCUSSION
Although a number of earlier studies (1, 13-16, 19, 21, 26),
including one conducted with the IgG2a MAb produced by
clone 34 (16), have affirmed a protective role of antibodies
against B. abortus in the murine model system, the data have
demonstrated statistically significant reduction, rather than
prevention, of infection. The present study was performed to
determine whether antibodies could actually prevent the
establishment of infection. Experimental conditions were
set, on the one hand, to favor that outcome, and on the
other, to provide as rigorous as possible a test of the
question. Therefore, the infecting strain was preincubated
with antibodies and the challenge dose was reduced in most
experiments to one just large enough to establish a chronic
infection. Concomitantly, we increased the sensitivity of our
assay system 10-fold, so that "infection-free" status meant
the presence of fewer than 13 brucellae in the entire spleen
and fewer than 39 in the entire liver. Experiments were
carried out for at least 4 and up to 6 weeks to ensure that
animals judged free of infection at early intervals did not
possess niduses of infection that would later produce detect-
able numbers of bacteria. The results of this study provide
VOL. 57, 1989
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TABLE 2. Numbers of B. abortus organisms in spleens and
antibody levels for LPS in serum of mice 6 weeks after
challenge with B. abortus opsonized with an IgG2a MAba
Amt of MAb Mouse No. of brucellae Antibody level
per mouse (ILg) no. in spleen (102) (slope x 1J3)b
50 1 _C 16
2 - 134
3 - 12
4 - 22
5 - 37
10 6 - 16
7 _ 9
8 - 8
9 - 11
10 - 10
1 11 - 8
12 - 7
13 - 68
14 - 87
15 - 154
0 16 - 49
17 1,600 178
18 6,200 27
19 18 181
20 1 34
a Infection was performed intravenously with approximately 100 CFU of
B. abortus 2308 following incubation for 30 min at 37°C with graded quantities
of MAb.
b Slope values from kinetics-based enzyme-linked immunosorbent assay
with B. abortus S-LPS (f6) as antigen. Slope values for normal mice were
approximately 10.
c_, s12 organisms per spleen. All mice with a culture-negative spleen also
had a culture-negative liver.
strong evidence that antibodies specific for the 0 polysac-
charide can prevent the establishment of infection with B.
abortus in a majority of normal mice, although success in
this endeavor was limited to the IgG2a MAb (Fig. 1). At 6
weeks p.i., antibody responses were negative in most mice
treated with the IgG2a MAb, as well as in a majority of those
infected with serum-opsonized bacteria (Table 2). Since the
latter group of mice would almost certainly have been
culture positive at 1 and 2 weeks p.i. (Fig. 3a), a negative
antibody response at 6 weeks p.i. must be interpreted to
signify either a lack of prior infection or the establishment of
a transient infection which was eliminated by 6 weeks p.i.
The possibility cannot be excluded that the passively trans-
ferred antibody itself inhibited the formation of antibody (17,
22, 27). However, the fact that negative responses were
more consistent in the group receiving a smaller quantity of
MAb (10 ,ug) (Table 2) suggests that antibody-mediated
immunosuppression was not the predominant factor.
Infection was prevented or rapidly terminated in the
majority of mice (73%) given a challenge dose of 500 CFU
preopsonized with 50 jig of the IgG2a MAb (Fig. 2a), but all
animals became infected when the dose was increased to
5,000 organisms (Fig. 2d). This may have been due to an
inadequate concentration of MAb, although with a challenge
dose of 100 CFU there was no evidence for a dose-response
effect with two of the three opsonins used, and the effective-
ness of the intermediate concentrations of the IgG2a MAb
(Fig. 1; Table 2) and whole serum (Fig. 3; Table 3) appeared
to have equaled or exceeded that of the highest concentra-
tions.
In contrast to the effects of the IgG2a MAb, opsonization
TABLE 3. Numbers of B. abortus in spleens and antibody levels
for LPS in serum of mice 6 weeks after challenge with
B. abortus opsonized with a polyclonal antiseruma
Antiserum Mouse No. of brucellae Antibody level
dilution no. in spleen (102) (slope x 103)b
1:5 1 -c 30
2 - 28
3 _ 20
4 - 38
5 0.4 42
1:50 6 - 13
7 - 15
8 - 10
9 - 13
10 -
12
1:500 11 - 10
12 - 12
13 - 11
14 110 191
15 - 15
0 16 80 230
17 13 195
18 0.2 60
19 1 98
20 19 182
21 1 221
22 2 150
a Infection was performed intravenously with approximately 100 CFU of
B. abortus 2308 following incubation for 30 min at 37°C with graded dilutions
of antiserum.
b Slope values from kinetics-based enzyme-linked immunosorbent assay
with B. abortus S-LPS (f6) as antigen. Slope values for normal mice were
approximately 10.
c
_12 organisms per spleen. All mice with a culture-negative spleen also
had a culture-negative liver.
with the IgGl MAb (Table 1) or with whole serum (Fig. 3a)
failed to prevent infection with B. abortus, although pre-
treatment with whole serum caused a markedly accelerated
elimination of infection in most mice, which was evident at 4
and 6 weeks p.i. (Fig. 3a). The basis for these differences has
not yet been established. It should be emphasized that few
direct comparisons among these preparations can be made in
the concentrations, affinities, or fine specificities of the
antibodies which they contained. Although all of the anti-
body preparations demonstrated opsonic activity in vivo,
and killing of B. abortus followed similar kinetics in conven-
tional medium (Fig. 4a), it is still probable that the IgG2a
MAb functioned more effectively in vivo. In mice, IgG2a
antibodies bind to the high-affinity type 1 Fc receptor (28)
and are active in complement fixation (11). These properties,
coupled with the high affinity of the clone 34 MAb (16),
would have resulted in rapid and stable binding of antibody
to both bacterial and phagocyte surfaces, resulting in effi-
cient opsonization and maximal Fc receptor-mediated trig-
gering of phagocyte function (4, 8). Although killed B.
abortus has been reported to cause preferential synthesis of
IgG2a antibody through stimulation of gamma interferon
secretion (7), antibodies of the IgG2a isotype form a very
low proportion of 0-polysaccharide-specific antibodies in
mice vaccinated with B. abortus endotoxin or LPS (10). This
is also reflected in the low frequency of 0-polysaccharide-
specific MAbs of the IgG2a isotype (L. G. Adams, unpub-
lished data). A low level of IgG2a antibodies in the serum
pool used in this study may afford a partial explanation for
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FIG. 4. Phagocytosis and killing of B. abortus 2308 by unelicited
mouse peritoneal macrophages. Bacterial cells were preincubated
with an IgG2a MAb (20 ,ug/ml), an IgGl MAb (1:10), a heat-
inactivated polyclonal antiserum pool (1:3,200), or normal heat-
inactivated mouse serum (1:3,200). Tests were performed with
conventional reagents (a) or with endotoxin-free reagents and pyro-
gen-free glassware (b). Percentages refer to the percentage of
intracellular bacteria surviving for 8 h after phagocytosis.
the incapacity of this preparation to prevent infection (Fig.
3a). Enhancement of phagocytosis and intracellular killing
probably constitute the principal functions of antibody in
mediating protection against B. abortus, in particular if the
inhibition of complement-mediated killing by antibodies of
IgG isotypes observed in cattle (5) extends to other species.
Variations among mice in isotypes of 0 antibodies mediating
crucial protective functions may have an important bearing
on the magnitude of protection afforded by vaccination with
strain 19 or on the rate of resolution of a primary infection,
which shows no correlation between overall levels of anti-
bodies and bacterial counts in organs (30) (Table 2).
The in vitro assays were performed to ensure that each of
the antibody preparations opsonized B. abortus and to
determine whether virulent B. abortus would be killed within
nonactivated macrophages in which cell function had been
stimulated following Fc receptor binding (4, 8). In accord
with prior reports (8, 31), phagocytosis of smooth B. abortus
was negligible in the absence of opsonins (Fig. 4). The data
(Fig. 4) indicate that opsonized B. abortus is effectively
killed only by macrophages which have been primed. Initial
attempts to enhance the killing of brucellae in endotoxin-free
medium by pretreating monocytes with LPS of B. abortus or
Escherichia coli O111:B4 proved inconclusive (C. G. San-
tisteban and A. J. Winter, unpublished data). Nevertheless,
the most probable source of monocyte priming was LPS, for
which this property is well documented (2, 9, 18) and can be
initiated within 1 h (18).
It seems reasonable to believe that in the cow, as well as
in the mouse, 0 polysaccharide-specific antibodies could
play an important role in protection and that the induction of
maximum protection in cattle may not be possible with
vaccines which fail to stimulate 0 antibodies of the appro-
priate isotypes. If this proves true, a solution would be
required for the interference caused by 0 antibodies in the
interpretation of serodiagnostic tests (25). Since the 0
polysaccharide ofB. abortus contains more than one epitope
(3, 6), one strategy might be a dissection of the epitopes into
those which are essential for protection and those which are
not. A vaccine could be constructed to incorporate only an
essential epitope, thus allowing ready distinction of cattle
which had been vaccinated from those responding to infec-
tion with field strains of B. abortus.
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